Clinical trials
Muscular Atrophy, Spinal trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 7 |
| Active, not recruiting | 6 |
| Terminated | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 6 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| Hoffmann-La Roche | 5 |
| Hospices Civils de Lyon | 4 |
| Institut de Myologie, France | 4 |
| Novartis Pharmaceuticals | 3 |
| Scholar Rock, Inc. | 3 |
| University Hospital, Rouen | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| CHU de Reims | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy, Spinal | 38 |
| Spinal Muscular Atrophies of Childhood | 7 |
| Muscular Atrophy | 6 |
| Neuromuscular Diseases | 5 |
| Bulbo-Spinal Atrophy, X-Linked | 3 |
| Muscular Diseases | 3 |
| Neuromuscular Manifestations | 3 |
| Atrophy | 2 |
| Charcot-Marie-Tooth Disease | 1 |
| Disease | 1 |
Trials
Showing 76 to 38 of 38. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.